Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
000411.SZ
STRONG BUYZhejiang Int'l Group Co.,Ltd. · Healthcare · China · $749M · Avg Vol: $13M/d
COMPANY DESCRIPTION
Zhejiang Int'l Group is a leading regional pharmaceutical distributor and healthcare logistics provider based in Zhejiang Province, China. The company operates an extensive distribution network supplying hospitals, clinics, and retail pharmacies, supported by advanced cold-chain logistics. Its strong regional market share and deep relationships with healthcare institutions establish a highly defensive business model.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 4.5B | 4.7B | 4.9B | 5.0B | 3.2% | 5.0B |
| EPS | 0.10 | 0.16 | 0.15 | 0.14 | 10.6% | 0.13 |
| Shares | 309.5M | 522.4M | 522.2M | 540.8M | +74.7% | 564.8M |
| Debt | 291.5M | 374.5M | 374.6M | 502.1M | 19.9% | 645.1M |
| Equity | 306.5M | 626.5M | 683.0M | 751.8M | 34.9% | — |
| Op CF | 57.6M | 62.6M | 60.4M | 52.4M | -3.1% | 237.8M |
| Inv CF | -24.4M | -9.6M | -42.5M | -99.4M | — | — |
| Fin CF | -194.9M | 53.6M | -26.9M | 81.8M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000411.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000411.SZ | Zhejiang Int'l Group Co.,Ltd.(you) | $749M | 83 | STRONG BUY |
| 600713.SS | Nanjing Pharmaceutical Group Company Limited | $977M | 77 | BUY |
| 300181.SZ | Zhejiang Jolly Pharmaceutical Co.,LTD | $1.3B | 85 | STRONG BUY |
| 1666.HK | Tong Ren Tang Technologies Co. Ltd. | $511M | 94 | STRONG BUY |
| 688710.SS | Shanghai InnoStar Bio-tech Co., Ltd. | $1.3B | 62 | HOLD |
| 300357.SZ | Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | $1.6B | 61 | HOLD |
| 600771.SS | GuangYuYuan Chinese Herbal Medicine Co., Ltd. | $916M | 48 | HOLD |
| 301507.SZ | Hangzhou Minsheng Healthcare Co., Ltd. | $633M | 44 | HOLD |
| 300006.SZ | Chongqing Lummy Pharmaceutical Co., Ltd. | $698M | 33 | SELL |
| 1093.HK | CSPC Pharmaceutical Group Limited | $9.7B | 74 | BUY |
Peer medians: ROE 4.7% · P/E 28.4x · Gross margin 52.5%